Lumea https://validator.w3.org/feed/docs/rss2.html Lumea Dermatology Better Grossing: BxCamera® BxLink™ Better Biopsy – BxBoard® Lumea Urology VIEWER+ HOME Draft HOME Lumea Named Overall State Winner for Science and Technology The Top 6 AI Solutions for Prostate Pathology Top 8 Global Digital Pathology Conferences to Attend in 2026 Top 10 AI Companies for Digital Pathology Top AI Companies for Digital Derm Pathology Research and Publications Comparative Analysis of 10% NBF Absorption Using Immersion and Sponge-Assisted Methods How the BxChip™ Delivers 60% Higher Grading Accuracy From QNS to Quality: Reducing RNA Degradation and Specimen Cancellations by 50% – a Case Study How Lumea Technology Delivers a 35% Reduction in Prostate Fragmentation Lumea BxChip® Now Available in European Markets The Lumea BxChip® Saves Labs Time, Money, and Improves Quality Verily and Lumea Announce Development Partnership Verily, Tempus, and Myriad Genetics To Present at The 2022 Digital Diagnostic Summit Lumea Selects Tempus to Advance AI-Driven Digital Pathology Solutions Lumea Partners with P4 Diagnostix® in First Integrated LIS Digital Pathology Solutions Platform of Its Kind Lumea and OptraSCAN Announce Partnership to Enable Seamless Adoption of Digital Pathology Acupath Adopts Lumea Digital Pathology  Lumea Elevates Digital Pathology Capabilities through Strategic Partnership with AIRA Matrix KLAS Research Highlights Lumea as a Prominent Leader in Clinical Use Digital Pathology Three digital pathology leaders converge to streamline processes, enhance diagnostics, and improve patient outcomes Lumea Recognized as Best of State Winner for Medical Innovation Lumea Unveils Standalone Version of their Smart Grossing Camera, Making Cutting-Edge Lab Efficiency Accessible to Everyone Digital Pathology Innovators to Converge at the 2024 Digital Diagnostic Summit Lumea Honored with 2024 Top Workplace Award by Salt Lake Tribune Lumea Announces Availability of Cxbladder™ Tests on BxLink™ Platform Lumea Expands Digital Pathology Horizons through Strategic Alliance with Mindpeak GmbH Lumea and Myriad Genetics Collaborate to Enhance Access to Biomarker and Hereditary Cancer Tests in BxLink The Digital Pathology Viewer You all Want is Now FDA Cleared Lumea, AIRA Matrix, and Acupath have Partnered to Provide a Diagnostic AI Solution for the URO17® Bladder Cancer Biomarker Lumea Enhances Digital Pathology Platform with AI-Powered Urine Cytology Solution Through AIxMed Partnership Lumea and Paige Partner to Advance AI-Powered Digital Pathology GI Alliance, the Nation’s Leading GI Network, Selects Lumea’s Viewer+ to Power Digital Pathology Transition Lumea Earns Prestigious Global and State Awards for Impact in Cancer Diagnostics Inc. 5000 Lists Lumea Among the Fastest-Growing Private Companies in America Lumea Recognized on the Utah Business Fast 50 List Lumea Honored with Two Prestigious Global Health & Pharma Awards in 2025 Lumea and Valar Labs Announce Partnership to Improve Bladder Cancer Treatment Decisions Lumea Partners with ZayaAI to Make A Digitally-Enabled LIS Globally Accessible Lumea Announces Collaboration with Cleveland Diagnostics to Enable Greater Access to IsoPSA® Testing Lumea and Voicebrook Announce Strategic Partnership to Advance Digital Pathology Workflows Lumea’s IMS Viewer+™ Achieves CE Marking Under IVDR, Expanding Clinical Use Across Europe